ES2101073T3 - Nuevos aza-androstano-derivados 17-beta-substituidos. - Google Patents
Nuevos aza-androstano-derivados 17-beta-substituidos.Info
- Publication number
- ES2101073T3 ES2101073T3 ES92810766T ES92810766T ES2101073T3 ES 2101073 T3 ES2101073 T3 ES 2101073T3 ES 92810766 T ES92810766 T ES 92810766T ES 92810766 T ES92810766 T ES 92810766T ES 2101073 T3 ES2101073 T3 ES 2101073T3
- Authority
- ES
- Spain
- Prior art keywords
- phe
- formula
- group
- substituted
- androstano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
COMPUESTOS DE LA FORMULA, DONDE LOS ATOMOS DE CARBONO 1 Y 2 ESTAN UNIDOS POR MEDIO DE UN ENLACE SENCILLO O UN DOBLE ENLACE, R1 EQUIVALE A HIDROGENO, METILO O ETILO, Y A EQUIVALE A UN GRUPO DE FORMULA O C1 CLOALQUILENO; UN GRUPO DE FORMULA R2 TIENE EL SIGNIFICADO DADO ARRIBA, Y ES UN ENLACE DIRECTO O UN C1 ADO EL CASO SUSTITUIDO; UN GRUPO DE FORMULA TIENE EL SIGNIFICADO DADO ARRIBA, O EQUIVALE A UN GRUPO Y INHIBIDORES DE LA 5O TRATAMIENTOS TERAPEUTICOS DE CUERPOS HUMANOS Y DE ANIMALES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH297891 | 1991-10-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2101073T3 true ES2101073T3 (es) | 1997-07-01 |
Family
ID=4245915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92810766T Expired - Lifetime ES2101073T3 (es) | 1991-10-09 | 1992-10-08 | Nuevos aza-androstano-derivados 17-beta-substituidos. |
Country Status (19)
Country | Link |
---|---|
US (2) | US5304562A (es) |
EP (1) | EP0538192B1 (es) |
JP (1) | JPH05213989A (es) |
KR (1) | KR930007969A (es) |
AT (1) | ATE152121T1 (es) |
AU (1) | AU657579B2 (es) |
CA (1) | CA2080054A1 (es) |
DE (1) | DE59208383D1 (es) |
DK (1) | DK0538192T3 (es) |
ES (1) | ES2101073T3 (es) |
FI (1) | FI924529A (es) |
GR (1) | GR3024013T3 (es) |
HU (1) | HUT62600A (es) |
IL (1) | IL103361A (es) |
MX (1) | MX9205792A (es) |
NO (1) | NO923911L (es) |
NZ (1) | NZ244640A (es) |
TW (1) | TW263513B (es) |
ZA (1) | ZA927747B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5304562A (en) * | 1991-10-09 | 1994-04-19 | Ciba-Geigy Corporation | 17β-substituted Aza-androstane derivatives |
WO1993023039A1 (en) * | 1992-05-20 | 1993-11-25 | Merck & Co., Inc. | Substituted 4-aza-5a-androstan-ones as 5a-reductase inhibitors |
RU94046044A (ru) * | 1992-05-20 | 1996-10-10 | Мерк Энд Ко. | Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения |
GB9210880D0 (en) * | 1992-05-21 | 1992-07-08 | Smithkline Beecham Corp | Compounds |
GB9216284D0 (en) * | 1992-07-31 | 1992-09-16 | Erba Carlo Spa | Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives |
HU212459B (en) * | 1992-10-02 | 1996-06-28 | Richter Gedeon Vegyeszet | Process for producing new 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them |
US5693810A (en) * | 1992-10-06 | 1997-12-02 | Merck & Co., Inc. | 17 β-carboxanilides of 4-aza-5α-androstan-3-ones as 5α-reductase inhibitors |
TW408127B (en) * | 1993-09-17 | 2000-10-11 | Glaxo Inc | Androstenones |
TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
US5470976A (en) * | 1994-09-07 | 1995-11-28 | Merck & Co., Inc. | Process for the stereoselective reduction of steroid enelactams |
US5543417A (en) * | 1994-10-21 | 1996-08-06 | Merck & Co., Inc. | Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents |
US5595996A (en) * | 1994-10-25 | 1997-01-21 | Merck & Co., Inc. | 7-substituted 4-aza cholanic acid derivatives and their use |
US5656613A (en) * | 1995-01-04 | 1997-08-12 | Merck & Co., Inc. | Treatment of hyperandrogenic conditions |
US6001844A (en) * | 1995-09-15 | 1999-12-14 | Merck & Co., Inc. | 4-Azasteroids for treatment of hyperandrogenic conditions |
EP0859761A4 (en) * | 1995-09-15 | 2000-01-26 | Merck & Co Inc | 4-AZASTEROIDES USED FOR THE TREATMENT OF HYPERANDROGENIC CONDITIONS |
US5998427A (en) * | 1998-05-14 | 1999-12-07 | Glaxo Wellcome Inc. | Androstenones |
US6645974B2 (en) | 2001-07-31 | 2003-11-11 | Merck & Co., Inc. | Androgen receptor modulators and methods for use thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4377584A (en) * | 1978-04-13 | 1983-03-22 | Merck & Co., Inc. | 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors |
US4760071A (en) * | 1984-02-27 | 1988-07-26 | Merck & Co., Inc. | 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors |
NZ211145A (en) * | 1984-02-27 | 1988-10-28 | Merck & Co Inc | 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions |
US5049562A (en) * | 1984-02-27 | 1991-09-17 | Merck & Co., Inc. | 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors |
GB8505862D0 (en) * | 1985-03-07 | 1985-04-11 | Erba Farmitalia | Steroidic 5alpha-reductase inhibitors |
DE3780778T2 (de) * | 1986-11-20 | 1993-01-14 | Merck & Co Inc | Topisches arzneimittel enthaltend 17-beta-methoxy-carbonyl-4-methyl-4-aza-5-alpha-androst-1-en-3-one. |
US4845104A (en) * | 1986-11-20 | 1989-07-04 | Merck & Co., Inc. | Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones |
US4888336A (en) * | 1987-01-28 | 1989-12-19 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
DE3888378T2 (de) * | 1987-04-03 | 1994-09-29 | Merck & Co Inc | Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen. |
US5237061A (en) * | 1988-10-31 | 1993-08-17 | Merck & Co., Inc. | Methods of synthesizing benign prostatic hypertropic agents and their intermediates |
DE69032648T2 (de) * | 1989-07-07 | 1999-04-08 | Endorecherche Inc., Ste-Foy, Quebec | Androgenderivate zur Hemming der Aktivität der Sexualsteroide |
CA2023157A1 (en) * | 1989-08-21 | 1991-02-22 | Gary H. Rasmusson | 17 beta-acyl-4-aza-5 alpha-androst-1-ene-3-ones as 5 alpha-reductase inhibitors |
US5120847A (en) * | 1990-08-27 | 1992-06-09 | Merck & Co., Inc. | Process for iodinating or brominating the α-methylenic carbon of a secondary amide |
IE76452B1 (en) * | 1990-10-29 | 1997-10-22 | Sankyo Co | Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use |
US5304562A (en) * | 1991-10-09 | 1994-04-19 | Ciba-Geigy Corporation | 17β-substituted Aza-androstane derivatives |
-
1992
- 1992-09-30 US US07/954,081 patent/US5304562A/en not_active Expired - Fee Related
- 1992-10-05 IL IL103361A patent/IL103361A/xx not_active IP Right Cessation
- 1992-10-07 FI FI924529A patent/FI924529A/fi not_active Application Discontinuation
- 1992-10-07 NZ NZ244640A patent/NZ244640A/en unknown
- 1992-10-07 CA CA002080054A patent/CA2080054A1/en not_active Abandoned
- 1992-10-07 AU AU26261/92A patent/AU657579B2/en not_active Ceased
- 1992-10-08 KR KR1019920018464A patent/KR930007969A/ko active IP Right Grant
- 1992-10-08 DK DK92810766.3T patent/DK0538192T3/da active
- 1992-10-08 ES ES92810766T patent/ES2101073T3/es not_active Expired - Lifetime
- 1992-10-08 MX MX9205792A patent/MX9205792A/es unknown
- 1992-10-08 NO NO92923911A patent/NO923911L/no unknown
- 1992-10-08 DE DE59208383T patent/DE59208383D1/de not_active Expired - Fee Related
- 1992-10-08 ZA ZA927747A patent/ZA927747B/xx unknown
- 1992-10-08 TW TW081108002A patent/TW263513B/zh active
- 1992-10-08 EP EP92810766A patent/EP0538192B1/de not_active Expired - Lifetime
- 1992-10-08 AT AT92810766T patent/ATE152121T1/de not_active IP Right Cessation
- 1992-10-08 HU HU9203189A patent/HUT62600A/hu unknown
- 1992-10-09 JP JP4271226A patent/JPH05213989A/ja active Pending
-
1993
- 1993-10-06 US US08/132,399 patent/US5378710A/en not_active Expired - Fee Related
-
1997
- 1997-07-08 GR GR970401668T patent/GR3024013T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ZA927747B (en) | 1993-04-13 |
FI924529A (fi) | 1993-04-10 |
FI924529A0 (fi) | 1992-10-07 |
DK0538192T3 (da) | 1997-05-20 |
JPH05213989A (ja) | 1993-08-24 |
TW263513B (es) | 1995-11-21 |
EP0538192B1 (de) | 1997-04-23 |
EP0538192A1 (de) | 1993-04-21 |
MX9205792A (es) | 1993-08-01 |
GR3024013T3 (en) | 1997-10-31 |
US5378710A (en) | 1995-01-03 |
NO923911L (no) | 1993-04-13 |
US5304562A (en) | 1994-04-19 |
HUT62600A (en) | 1993-05-28 |
ATE152121T1 (de) | 1997-05-15 |
DE59208383D1 (de) | 1997-05-28 |
NZ244640A (en) | 1994-12-22 |
AU2626192A (en) | 1993-04-22 |
NO923911D0 (no) | 1992-10-08 |
IL103361A (en) | 1997-06-10 |
KR930007969A (ko) | 1993-05-20 |
CA2080054A1 (en) | 1993-04-10 |
IL103361A0 (en) | 1993-03-15 |
AU657579B2 (en) | 1995-03-16 |
HU9203189D0 (en) | 1992-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2101073T3 (es) | Nuevos aza-androstano-derivados 17-beta-substituidos. | |
ES8603455A1 (es) | Un metodo para preparar derivados de piperazina | |
DE3789967D1 (de) | Anwendung von monoaminakridinen bei mangelerscheinungen des cholinergen nervensystems. | |
HUP0002495A1 (hu) | VLA-4 Által közvetített leukocita adhéziót gátló dipeptidszármazékok és rokon vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
BG105271A (en) | 1h-imidazopyridine derivatives | |
DE69725113D1 (de) | Azetidin- und Pyrrolidinderivate | |
BG104853A (en) | Thienylazolylalcoxyethanamines, their preparation and their application as medicaments | |
DK0694545T3 (da) | Substituerede dibenzoxazepinforbindelser, farmaceutiske sammensætninger og anvendelsesmetoder | |
DE69612374D1 (de) | Derivate des carbapenem-3-carbonsäureesters | |
IE871867L (en) | Solutions of oxazaphosphorins | |
NO163735C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkyl-beta-carboliner. | |
ATE79257T1 (de) | Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
ES2073258T3 (es) | Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica. | |
DK288686A (da) | Farmaceutiske praeparater | |
ATE70274T1 (de) | Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide. | |
ATE41146T1 (de) | Irreversible dopamin-b-hydroxylase-inhibitoren. | |
NO167746C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive muramylpeptidderivater. | |
NO173057C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzanilidderivater | |
IL103551A0 (en) | Butyric acid derivatives | |
NO870423L (no) | 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter. | |
ATE139441T1 (de) | Verwendung von 2-iminothiazolidin-4-onderivaten als neuartige arzneimittelwirkstoffe | |
ATE247903T1 (de) | Fungizide zusammensetzung enthaltend ein n- benzoyl-n'-phenyl-harnstoff derivat | |
ATE63309T1 (de) | 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel. | |
ES2183636T3 (es) | 4'-sustituido-4', 5'-dihidropsoralenos y sus usos terapeuticos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 538192 Country of ref document: ES |